Anna is from England and recently finished her undergraduate degree. She has an interest in medicine and enjoys writing. In her spare time she likes to cook, hike, and hang out with cats.

    The FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma
    Bru-nO / Pixabay

    The FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma

    9% Copyscape An investigational drug called CLR 131 has received Rare Pediatric Disease Designation from the US FDA for the treatment of Ewing’s sarcoma. The source press release can be…

    Continue Reading The FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma
    A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say
    felixioncool / Pixabay

    A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say

    A research team led by scientists from the Beth Israel Deaconess Medical Center (BIDMC) have found that arsenic, in combination with the drug all-trans retinoic acid (ATRA), may have the potential…

    Continue Reading A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say
    Orthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study
    ashokorg0 / Pixabay

    Orthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study

    A recently published study in the Journal of Biosciences and Medicines has concluded that orthoses may help to improve the gait and balance of patients with Charcot-Marie-Tooth disease. Orthoses are…

    Continue Reading Orthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study
    The Genetic and Developmental Processes Underlying Pachygyria are Explored in a Recent Study
    ColiN00B / Pixabay

    The Genetic and Developmental Processes Underlying Pachygyria are Explored in a Recent Study

    A recently published paper called ‘Biallelic loss of human CTNNA2, encoding αN-catenin, leads to ARP2/3 complex overactivity and disordered cortical neuronal migration’ outlines new research into the genetic basis of…

    Continue Reading The Genetic and Developmental Processes Underlying Pachygyria are Explored in a Recent Study
    A Clinical Trial of Gemcabene in Paediatric Patients with Non-Alcoholic Fatty Liver Disease Has Been Stopped Following Safety Concerns
    ernestoeslava / Pixabay

    A Clinical Trial of Gemcabene in Paediatric Patients with Non-Alcoholic Fatty Liver Disease Has Been Stopped Following Safety Concerns

    Gemphire Therapeutics Inc. has been recommended to stop a clinical trial by the Data and Safety Monitoring Board at Emory University School of Medicine. The clinical trial, which ran into…

    Continue Reading A Clinical Trial of Gemcabene in Paediatric Patients with Non-Alcoholic Fatty Liver Disease Has Been Stopped Following Safety Concerns

    Results from a Phase 3 Study of Recorlev as a Potential Treatment for Cushing’s Syndrome Have Been Released

    The top-line results of a pivotal Phase 3 study investigating the drug recorlevTM (levoketoconazole) in patients with endogenous Cushing’s syndrome have been released. The source article, which contains more detailed information,…

    Continue Reading Results from a Phase 3 Study of Recorlev as a Potential Treatment for Cushing’s Syndrome Have Been Released
    Orphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer
    Free-Photos / Pixabay

    Orphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer

    An investigational drug called ALT-P7 is being developed as a potential medicine for certain forms of cancer. The drug has received Orphan Drug Designation for the treatment of gastric cancer…

    Continue Reading Orphan Drug Status Has Been Awarded to an Investigational Drug For the Treatment of Stomach Cancer

    The FDA Has Granted Orphan Drug Status to an Experimental Drug to Treat Amyloidosis

    The US Food and Drug Administration (FDA) has awarded Orphan Drug Designation to the experimental drug ALN-TTRsc02. Alnylam Pharmaceuticals Inc. is developing ALN-TTRsc02 as a possible treatment for transthyretin-mediated amyloidosis.…

    Continue Reading The FDA Has Granted Orphan Drug Status to an Experimental Drug to Treat Amyloidosis
    Orphan Drug Designation Has Been Awarded to Selumetinib for the Treatment of Neurofibromatosis Type 1
    Source: Pixabay.com

    Orphan Drug Designation Has Been Awarded to Selumetinib for the Treatment of Neurofibromatosis Type 1

    The European Medicines Agency has awarded Orphan Drug designation to selumetinib for the treatment of neurofibromatosis type 1. You can read the source press release here, on Merck’s website. About…

    Continue Reading Orphan Drug Designation Has Been Awarded to Selumetinib for the Treatment of Neurofibromatosis Type 1
    There is No Ehlers-Danlos Syndrome Nutshell, But Here’s an Overview of the Known Types
    qimono / Pixabay

    There is No Ehlers-Danlos Syndrome Nutshell, But Here’s an Overview of the Known Types

    Ehlers-Danlos syndromes (EDS) are a group of rare conditions that affect the connective tissue and can be inherited. Connective tissue lies between tissues and organs throughout the body and helps…

    Continue Reading There is No Ehlers-Danlos Syndrome Nutshell, But Here’s an Overview of the Known Types
    OMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation
    nosheep / Pixabay

    OMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation

    According to a source article on Business Wire that can be found here, the Committee for Orphan Medicinal Products (part of the European Medicines Agency) has recommended that the experimental…

    Continue Reading OMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation
    The First Patient Has Been Dosed on a Clinical Trial of an Investigational Gene Therapy for the Treatment of GSDIa
    qimono / Pixabay

    The First Patient Has Been Dosed on a Clinical Trial of an Investigational Gene Therapy for the Treatment of GSDIa

    According to a source article that can be found here on Ultragenyx’s website, the first patient has been dosed in a trial of an investigational gene therapy called DTX401 that…

    Continue Reading The First Patient Has Been Dosed on a Clinical Trial of an Investigational Gene Therapy for the Treatment of GSDIa
    A Planned Study Will Investigate the Effects of an Investigational Drug in Children with Glioma
    DarkoStojanovic / Pixabay

    A Planned Study Will Investigate the Effects of an Investigational Drug in Children with Glioma

    A study is planned to investigate the effects of the experimental drug PTC596 in children with recently diagnosed diffuse intrinsic pontine glioma and high-grade glioma. The study is made up…

    Continue Reading A Planned Study Will Investigate the Effects of an Investigational Drug in Children with Glioma

    Results From Studies of an Experimental Drug for Chronic Kidney Disease Have Been Announced

    Results from two studies looking at the effects of an experimental drug (bardoxolone) on kidney function in patients with chronic kidney disease (CKD) have been released. One of the studies…

    Continue Reading Results From Studies of an Experimental Drug for Chronic Kidney Disease Have Been Announced
    October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
    mohamed_hassan / Pixabay

    October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease

    An ongoing Phase 3 clinical trial program is investigating the drug PXT3003 as an experimental treatment for Charcot-Marie-Tooth disease type 1A in adults. Pharnext SA says that they expect to…

    Continue Reading October 2018 is the Expected Date for Top-Line Results From a Phase 3 Trial of an Experimental Treatment for Charcot-Marie-Tooth Disease
    The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
    rawpixel / Pixabay

    The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome

    The first patient has been enrolled onto a Phase 3 clinical trial investigating topical dermal reproxalap as a possible treatment for Sjögren-Larsson syndrome associated ichthyosis. The original article can be read…

    Continue Reading The First Patient Has Been Enrolled in a Study for Sjögren-Larsson Syndrome
    Researchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease
    kaboompics / Pixabay

    Researchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease

    Researchers have investigated whether self-management electronic health (eHealth) interventions, such as text messaging, apps, and online cognitive-behavioural therapy, should be used to help patients with sickle cell disease self-manage the…

    Continue Reading Researchers Investigated the Role of Technology in Self-Management of Sickle Cell Disease